Compassionate use of experimental therapies: who should decide?
Abstract In addition to being an example of unsubstantiated hype about regenerative medicine, the controversy around the Italy‐based Stamina Foundation's unproven stem cell therapy represents another chapter in a continuing debate about how to balance patients' requests for early access to...
Saved in:
| Main Author: | Patricia J Zettler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2015-07-01
|
| Series: | EMBO Molecular Medicine |
| Online Access: | https://doi.org/10.15252/emmm.201505262 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Competing Interests: a Reader Should Decide
by: Ivan A. Deev
Published: (2016-12-01) -
Name-calling and jokes: should an interpreter decide?
by: Svetlana Polskaya
Published: (2007-07-01) -
Deciding for Therapy: Deciding for Peace of Mind
by: Janyne Sattler
Published: (2022-03-01) -
‘Frontier AI,’ Power, and the Public Interest: Who Benefits, Who Decides?
by: David Leslie, et al.
Published: (2024-09-01) -
Observing the observer (II): deciding when to decide.
by: Jean Daunizeau, et al.
Published: (2010-12-01)